1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Mortality Risk in Heart Failure No Higher with Losartan – MedPage Today

April 10, 2012Organ Failureadmin

Mortality Risk in Heart Failure No Higher with Losartan
MedPage Today
Note that angiotensin II receptor blockers as a class are currently recommended for use in patients with heart failure who are intolerant of ACE inhibitors. However, some observational studies suggest that losartan may be associated with increased ...
Study Evaluates Losartan Efficacy in Heart FailureForbes
No mortality risk for losartan vs candesartan seen in heart failureTheHeart.Org
JAMA: HF patients given high-dose losartan not at increased risk of deathCardiovascular Business
Journal of American Medical Association (subscription)
all 14 news articles »

Post navigation

← Common Blood Pressure Drug Safe for Heart Failure: Study – U.S. News & World Report Biogen Idec Gearing Up For Major Launches – Seeking Alpha →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos